Allison Eckard to Biomarkers
This is a "connection" page, showing publications Allison Eckard has written about Biomarkers.
Connection Strength
0.787
-
Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021 05; 147(5).
Score: 0.122
-
Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation. J Acquir Immune Defic Syndr. 2021 02 01; 86(2):231-239.
Score: 0.122
-
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther. 2018; 23(4):315-324.
Score: 0.098
-
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):539-546.
Score: 0.098
-
Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation. Antivir Ther. 2017; 22(8):669-680.
Score: 0.092
-
Kallistatin levels in HIV-infected patients and effects of statin therapy. Biomarkers. 2017 Feb; 22(1):55-62.
Score: 0.090
-
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014 Apr 15; 209(8):1156-64.
Score: 0.075
-
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther. 2012; 17(6):1069-78.
Score: 0.068
-
Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. J Biomech. 2016 09 06; 49(13):2584-2592.
Score: 0.022